Four investment areas

Within the four target investment areas, Mérieux Développement selects companies whose project is a real challenge for health and nutrition and finances the development or marketing of products and services with high added value.

In vitro Diagnostics and Life science tools

Molecular diagnostics, Point of Care / Rapid Tests, Sample preparation, Clinical and industrial microbiology, Clinically-validated biomarkers,  Management & Data analysis.

Medical Devices

Imaging platforms and agents, Minimally invasive surgical and interventional devices, Ophtalmologic products, Biomaterials, Patient management software.

Patient management services

Management of home care, Specialized care for chronic and genetic diseases, Remote patient monitoring

Preventive medicine and nutrition

Anti-infective agents, vaccines and tools, Nutrigenic services, Clinically validated nutraceuticals.

What entrepreneurs say

  • "We found Mérieux Développement staff to be actively involved in strategic decisions but also respectful of our management. Besides the level of attention they put in the quality of our relationship, their support to our global business expansion is real. "
    Eric MOTTAY
    Amplitude
  • "Using their insight and intelligence, Merieux Développement provides more than just critical funding for companies within their portfolio -- they guide in strategic positioning and share development and commercialization experience to help ensure the success of their portfolio companies. They anticipate future industry developments and facilitate the pathway for companies to achieve their objectives. Partnering with Merieux brings bright minds together to drive the future of healthcare."
    Emily LEPROUST
    Twist Bioscience
  • "I am very pleased and proud to welcome Alexandre Mérieux onto the Ceva Board. He represents a great family with long history of industrial expertise and long term vision who have always believed that animal and human health should be managed all together."
    Marc PRIKAZSKY
    Ceva
  • "The Merieux team have been great partners in helping build Kalila Medical from concept, through regulatory approvals, to product launch. They have brought both capital and fresh perspectives to the table."
    Mike DINEEN
    Kalila
  • "We are thrilled by the opportunity of working together with Mérieux Développement, whose industrial experience and global healthcare network will be extremely valuable in helping us to achieve our goal of becoming a market leader in the OSA device segment."
    Alex RAPOPORT
    Ninox
  • "."
    Michele LESIEUR
    Supersonic Imagine
  • ""we warmly welcome Merieux Developpement to our multinational syndicate of valued investors, With well-earned reputations for deep diligence and a commitment to their portfolio companies, we couldn't ask for better partners for this next exciting stage of our company's evolution." "
    David VAN METER
    Ivantis

Our investments

Since 2010, Mérieux Développement has invested in 20 companies, ranging from start-ups to profitable established companies within the healthcare space.

(MUTZIG, France)
(PESSAC, France)
(SAINT-PRIEST, France)
(LIBOURNE, France)
(INGLEWWOD, USA)
(Irvine, ETATS UNIS)
(CAMPBELL, USA )
(VENISSIEUX, France)
(LUXEMBURG, Luxemburg )
(Vertou, FRANCE)
(RISHON LEZION, Israel)
(LYON, France)
(ROCKVILLE, USA)
(CAMBRIDGE, USA)
(PLEASANTON, USA)
(AIX EN PROVENCE, France)
(SAN FRANCISCO, CA - USA )
(OULU, Finlande)
Global footprint of Mérieux Group